| Catalog Number |
04P54-25 |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
01/21/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient information: no additional patient information was provided.
|
| |
|
Event or Problem Description
|
|
The customer reported a (b)(6) architect hbsag qualitative confirmatory result for one bone marrow transplant patient.Sample id (b)(6) generated a confirmed (b)(6) result of (b)(6) with 75% neutralization.The customer further indicated the sample generated a (b)(6) architect hbsag qualitative result (b)(6).No adverse impact to patient management was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, in-house testing, review of manufacturing documents and a review of labeling.Review of complaint activity did not identify any adverse or non-statistical trends for the architect hbsag qualitative confirmatory assay.Normal complaint activity was identified for reagent lot 91396fn00.Investigation testing was performed for architect hbsag qualitative confirmatory reagent lot 91396fn00.Testing of panels which mimic patient samples was performed using a retained kit of lot 91396fn00.All specifications were met indicating that the lot is performing acceptably.Manufacturing documentation for the likely cause lot was reviewed and did not identify any issues associated with false positive results.Labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the architect hbsag qualitative confirmatory assay was identified.
|
| |
|
Search Alerts/Recalls
|